Our LINQ platform is the software that plans, schedules, and drives life-science labs. Our clients run labs for cancer diagnostics, drug discovery, cell manufacturing, synthetic biology and more.
This role owns the interface to the lab — not just the UI, but every surface someone builds on or acts through: the app a scientist touches, the APIs and SDK an integrator builds on, the CLI an engineer scripts with, the agent surface a model acts through. Most product interfaces are forms over a database. Ours front a physical world that changes by itself — robots act, schedules change, instruments fail — and every one of those surfaces has to keep its user genuinely in control.
We're building the next generation of our interfaces — AI-native from the ground up: personalised to role and behaviour, UI generated on the fly where it earns its place, and agents working in the product alongside the people using it. This is a role for someone user-obsessed — the platform underneath is enormously capable and enormously complex, and the product wins by how much of that complexity users never have to see. And the stakes only grow: the more autonomous the lab becomes, the more the interface matters, because it's where human judgment enters the system.
Explaining automation to a scientist. When the plan changes underneath the user, the interface has to show what moved and why. When a workflow can't run, 500 is not an answer a human can act on — turning our engine's output into something a scientist can fix is an unsolved design problem. And the timeline it lives on is long: processes that run for months, hundreds of plates in flight.
The worst moment is the main event. Users arrive precisely when something has gone wrong: a plate misplaced, a task failed, retry-or-failover decisions with live samples degrading while they think. The interface has to put the right context in front of them — not a wall of state — at the exact moment the stakes are highest.
Authoring is programming, whether we admit it or not. Scientists design workflows on a canvas today, and it's static: you express an intent, submit it, and find out later whether it actually runs. It should feel like an IDE — validation as you type, the constraints visible while you're authoring, simulate the run you're designing and watch it execute before a single robot moves. Design and execution are disconnected today, and closing that gap is one of the biggest wins available to us.
Interfaces that build themselves. An operator, a scientist, and a lab manager should not see the same screen. Surfaces personalised to role and behaviour, generated where it helps — and the open question you'd own: where does generated UI aid discoverability, and where does it erode trust?
Four front doors, one lab. A scientist in the browser, an integrator on the API and SDK, an engineer scripting the CLI, an agent acting over MCP — the same capabilities have to show up on every surface, each one idiomatic to its user. An API that is hard to use correctly is wrong, and DX is UX: the developer and the agent are users too.
We use the right tool for the job.
London, 3 days a week in office (near Angel).
👀 Eye Care
🚲 Salary Sacrifice - Bike & Tech
🧘🏼♀️ Wellbeing & Support
☀️ Wellbeing & Development Allowance
💙 Spill & Employee Assistance Programme
🫂 Group Life & Critical Illness cover
We are an equal-opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees. Discrimination of any kind based on race, colour, religion, gender, sexual orientation, gender identity or expression, national origin, age, genetic information, disability, or veteran status is strictly prohibited.

Automata’s mission is to empower scientists and organizations to accelerate discovery and improve outcomes in life sciences through intelligent lab automation. By uniting cutting-edge robotics and flexible, intelligent software in its products, Automata enables laboratories to automate, optimize and scale complex workflows seamlessly.
Automata’s solutions are trusted across pharma, biotech, genomics and life sciences sectors, helping teams minimize manual work, boost throughput and accelerate breakthrough science with the lab of the future.